FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1767927283> ?p ?o ?g. }

• W1767927283 endingPage "2752" @default.
• W1767927283 startingPage "2745" @default.
• W1767927283 abstract "Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity associated with clinically significant impairment in functioning. ADHD has an early onset, but frequently persists, with a prevalence estimate of 4% in adults. Dasotraline is a novel compound that is a potent inhibitor of dopamine and norepinephrine transporters that achieves stable plasma concentrations with once-daily dosing. In this study, adult outpatients meeting DSM-IV-TR criteria for ADHD were randomized to 4 weeks of double-blind, once-daily treatment with dasotraline 4 and 8 mg/day or placebo. The primary efficacy end point was change from baseline at week 4 in the ADHD Rating Scale, Version IV (ADHD RS-IV) total score. Secondary efficacy end points included the Clinical Global Impression, Severity (CGI-S) scale, modified for ADHD symptoms. Least squares (LS) mean improvements at week 4 in ADHD RS-IV total score were significantly greater for dasotraline 8 mg/day vs placebo (-13.9 vs -9.7; P=0.019), and nonsignificantly greater for 4 mg/day (-12.4; P=0.076). The LS mean improvements in modified CGI-S were significantly greater at week 4 for dasotraline 8 mg/day vs placebo (-1.1 vs -0.7; P=0.013), and for 4 mg/day vs placebo (-1.1 vs -0.7; P=0.021). The most frequent adverse events reported were insomnia, decreased appetite, nausea, and dry mouth. Discontinuations due to treatment-emergent adverse events were 10.3% and 27.8% of patients in 4 and 8 mg/day treatment groups, respectively. This study provides preliminary evidence that once-daily dosing with dasotraline, a long-acting, dual monoamine reuptake inhibitor, may be a safe and efficacious treatment for adult ADHD." @default.
• W1767927283 created "2016-06-24" @default.
• W1767927283 creator A5001940742 @default.
• W1767927283 creator A5020478743 @default.
• W1767927283 creator A5063897129 @default.
• W1767927283 creator A5066553937 @default.
• W1767927283 creator A5068191739 @default.
• W1767927283 creator A5079968486 @default.
• W1767927283 creator A5084126298 @default.
• W1767927283 date "2015-05-07" @default.
• W1767927283 modified "2023-10-14" @default.
• W1767927283 title "Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults" @default.
• W1767927283 cites W1885238897 @default.
• W1767927283 cites W1967986347 @default.
• W1767927283 cites W1969714842 @default.
• W1767927283 cites W1973824257 @default.
• W1767927283 cites W1976172596 @default.
• W1767927283 cites W1980060496 @default.
• W1767927283 cites W1994925343 @default.
• W1767927283 cites W2010073589 @default.
• W1767927283 cites W2010604180 @default.
• W1767927283 cites W2017788861 @default.
• W1767927283 cites W2039980027 @default.
• W1767927283 cites W2046349278 @default.
• W1767927283 cites W2049728585 @default.
• W1767927283 cites W2052080148 @default.
• W1767927283 cites W2055002512 @default.
• W1767927283 cites W2081695582 @default.
• W1767927283 cites W2082850379 @default.
• W1767927283 cites W2085046856 @default.
• W1767927283 cites W2101650598 @default.
• W1767927283 cites W2110412456 @default.
• W1767927283 cites W2111112265 @default.
• W1767927283 cites W2116795024 @default.
• W1767927283 cites W2127901933 @default.
• W1767927283 cites W2148083007 @default.
• W1767927283 cites W2159881136 @default.
• W1767927283 cites W2171147935 @default.
• W1767927283 cites W2992831435 @default.
• W1767927283 cites W3171418018 @default.
• W1767927283 cites W4236486344 @default.
• W1767927283 cites W4239633310 @default.
• W1767927283 cites W4247665917 @default.
• W1767927283 doi "https://doi.org/10.1038/npp.2015.124" @default.
• W1767927283 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4864650" @default.
• W1767927283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25948101" @default.
• W1767927283 hasPublicationYear "2015" @default.
• W1767927283 type Work @default.
• W1767927283 sameAs 1767927283 @default.
• W1767927283 citedByCount "43" @default.
• W1767927283 countsByYear W17679272832015 @default.
• W1767927283 countsByYear W17679272832016 @default.
• W1767927283 countsByYear W17679272832017 @default.
• W1767927283 countsByYear W17679272832018 @default.
• W1767927283 countsByYear W17679272832019 @default.
• W1767927283 countsByYear W17679272832020 @default.
• W1767927283 countsByYear W17679272832021 @default.
• W1767927283 countsByYear W17679272832022 @default.
• W1767927283 countsByYear W17679272832023 @default.
• W1767927283 crossrefType "journal-article" @default.
• W1767927283 hasAuthorship W1767927283A5001940742 @default.
• W1767927283 hasAuthorship W1767927283A5020478743 @default.
• W1767927283 hasAuthorship W1767927283A5063897129 @default.
• W1767927283 hasAuthorship W1767927283A5066553937 @default.
• W1767927283 hasAuthorship W1767927283A5068191739 @default.
• W1767927283 hasAuthorship W1767927283A5079968486 @default.
• W1767927283 hasAuthorship W1767927283A5084126298 @default.
• W1767927283 hasBestOaLocation W17679272831 @default.
• W1767927283 hasConcept C118552586 @default.
• W1767927283 hasConcept C126322002 @default.
• W1767927283 hasConcept C142724271 @default.
• W1767927283 hasConcept C15744967 @default.
• W1767927283 hasConcept C168563851 @default.
• W1767927283 hasConcept C197934379 @default.
• W1767927283 hasConcept C204787440 @default.
• W1767927283 hasConcept C27081682 @default.
• W1767927283 hasConcept C2776000289 @default.
• W1767927283 hasConcept C2780319597 @default.
• W1767927283 hasConcept C2780580376 @default.
• W1767927283 hasConcept C2780783007 @default.
• W1767927283 hasConcept C71924100 @default.
• W1767927283 hasConceptScore W1767927283C118552586 @default.
• W1767927283 hasConceptScore W1767927283C126322002 @default.
• W1767927283 hasConceptScore W1767927283C142724271 @default.
• W1767927283 hasConceptScore W1767927283C15744967 @default.
• W1767927283 hasConceptScore W1767927283C168563851 @default.
• W1767927283 hasConceptScore W1767927283C197934379 @default.
• W1767927283 hasConceptScore W1767927283C204787440 @default.
• W1767927283 hasConceptScore W1767927283C27081682 @default.
• W1767927283 hasConceptScore W1767927283C2776000289 @default.
• W1767927283 hasConceptScore W1767927283C2780319597 @default.
• W1767927283 hasConceptScore W1767927283C2780580376 @default.
• W1767927283 hasConceptScore W1767927283C2780783007 @default.
• W1767927283 hasConceptScore W1767927283C71924100 @default.
• W1767927283 hasIssue "12" @default.
• W1767927283 hasLocation W17679272831 @default.
• W1767927283 hasLocation W17679272832 @default.
• W1767927283 hasLocation W17679272833 @default.

• next